Actively Recruiting
Association Between Postoperative Administration of L-Arginine and CSA-AKI
Led by Xijing Hospital · Updated on 2025-04-04
7000
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To investigate the association between the the early administration of L-Arginine after CPB-assisted cardiac surgery and the incidence of CS-AKI in adult patients. To test if it can reduce the incidence of post-operative AKI.
CONDITIONS
Official Title
Association Between Postoperative Administration of L-Arginine and CSA-AKI
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients (over 18 years old)
- Underwent cardiopulmonary bypass (CPB)-assisted cardiac surgery
- Admitted to intensive care unit (ICU) after surgery
You will not qualify if you...
- Congenital heart disease
- Underwent deep hypothermic circulatory arrest (DHCA)
- Estimated glomerular filtration rate (eGFR) below 30 mL/min/1.73 m²
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Xijing Hospital
Xi'an, Shaanxi, China, 710032
Actively Recruiting
Research Team
Z
Ziyu Zheng
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here